India Losing Drug Exports To U.S. As China, S. Korea Exports Grow
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry may be losing its reputation as a sector immune to financial crises, a reputation that has been attracting foreign investors. A recent study showed drug exports from India to the United States fell by 37 percent between October and February. The decline contradicts expectations that the emphases by several governments on prescribing generics meant prosperity for the highly fragmented Indian industry. Research shows China and South Korea are growing in exports to the United States while India's is in decline. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.